These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5154400)

  • 41. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

  • 42. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
    Roe DA
    Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
    [No Abstract]   [Full Text] [Related]  

  • 43. Response of hyperlipoproteinemia to colestipol.
    Sachs BA; Wolfman L
    N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
    [No Abstract]   [Full Text] [Related]  

  • 44. [Atherosclerosis and Regelan].
    Schwaar R
    Praxis; 1966 Aug; 55(31):875-80. PubMed ID: 5953569
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug therapy of hyperlipidemia.
    Prihoda JS; Illingworth DR
    Curr Probl Cardiol; 1992 Sep; 17(9):545-605. PubMed ID: 1446461
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative treatment of hyperlipoproteinaemias in chimpanzees.
    Vastesaeger M; Blaton V; Declercq B; Vercruysse J; Vandamme D; Peeters H; Mortelmans J
    Acta Zool Pathol Antverp; 1974; 58(0):79-96. PubMed ID: 4365833
    [No Abstract]   [Full Text] [Related]  

  • 48. Measures to reduce the serum lipid levels in coronary heart disease.
    Connor WE
    Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837
    [No Abstract]   [Full Text] [Related]  

  • 49. [Drug therapy of essential hypercholesteremia?].
    Schettler G
    Dtsch Med Wochenschr; 1968 Sep; 93(37):1779. PubMed ID: 5681549
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 51. Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin).
    Ballantyne CM; Jones PH; Payton-Ross C; Patsch W; Short HD; Noon GP; Gotto AM; DeBakey ME; Young JB
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):60-2. PubMed ID: 3303569
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparative study of the effects of cholestyramine and neomycin in the treatment of type II hyperlipoproteinaemia.
    Schade RW; van't Laar A; Majoor CL; Jansen AP
    Acta Med Scand; 1976; 199(3):175-80. PubMed ID: 176876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of hyperlipidemia.
    Levy RI; Morganroth J; Rifkind BM
    N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of coronary artery disease.
    Br Med J; 1969 Jan; 1(5635):37-8. PubMed ID: 4973519
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effects of clofibrate in the treatment of hyperlipidemia. (Apropos of 61 cases)].
    Warembourg H; Jaillard J
    Rev Atheroscler (Paris); 1966; 8(1):53-5. PubMed ID: 5961028
    [No Abstract]   [Full Text] [Related]  

  • 56. Appraisal of clofibrate as a hypolipidemic agent.
    Sachs BA
    Am Heart J; 1968 May; 75(5):707-10. PubMed ID: 5645992
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 58. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of lipolytic drugs.
    Geill T
    Gerontol Clin (Basel); 1965; 7(6):321-9. PubMed ID: 5871676
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.